Singer Nicholas Jason
Insider CIK 1828224 · OTRA Chief Executive Officer, Director, 10% owner · BTX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2022-12-02 | 2022-12-06 | 141,644 | $0.13 | $18.4K | 141,644 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy deriv | 2022-12-02 | 2022-12-06 | 424,928 | $0.13 | $55.2K | 424,928 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2022-12-02 | 2022-12-06 | 70,822 | $3.28 | $232.3K | 121,822 | SEC↗ |
| ERNA Eterna Therapeutics Inc. | P Buy | 2022-12-02 | 2022-12-06 | 212,464 | $3.28 | $696.9K | 266,214 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2022-08-01 | 2022-08-03 | 165,800 | — | $0 | 165,800 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2022-08-01 | 2022-08-03 | 146,100 | — | $0 | 146,100 | SEC↗ |
| OTRA OTR Acquisition Corp. | J Other deriv | 2022-05-20 | 2022-05-20 | 1,305,918 | — | $0 | 421,759 | SEC↗ |
| OTRA OTR Acquisition Corp. | J Other deriv | 2022-05-20 | 2022-05-20 | 762,634 | — | $0 | 0 | SEC↗ |
| OTRA OTR Acquisition Corp. | C Conversion deriv | 2022-05-20 | 2022-05-20 | 421,759 | — | $0 | 0 | SEC↗ |
| OTRA OTR Acquisition Corp. | J Other | 2022-05-20 | 2022-05-20 | 421,759 | — | $0 | 0 | SEC↗ |
| OTRA OTR Acquisition Corp. | C Conversion | 2022-05-20 | 2022-05-20 | 421,759 | — | $0 | 421,759 | SEC↗ |
| OTRA OTR Acquisition Corp. | J Other deriv | 2022-05-06 | 2022-05-10 | 884,161 | — | $0 | 1,727,677 | SEC↗ |
| OTRA OTR Acquisition Corp. | J Other deriv | 2022-05-06 | 2022-05-10 | 5,055,123 | — | $0 | 762,634 | SEC↗ |